- Home
- TWST vs BCRX Comparison
TWST vs BCRX Comparison
Compare TWST & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- BCRX
- Stock Information
- Founded
- TWST 2013
- BCRX 1986
- Country
- TWST United States
- BCRX United States
- Employees
- TWST N/A
- BCRX N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWST Health Care
- BCRX Health Care
- Exchange
- TWST Nasdaq
- BCRX Nasdaq
- Market Cap
- TWST 2.3B
- BCRX 1.9B
- IPO Year
- TWST 2018
- BCRX 1994
- Fundamental
- Price
- TWST $28.84
- BCRX $8.45
- Analyst Decision
- TWST Buy
- BCRX Strong Buy
- Analyst Count
- TWST 10
- BCRX 10
- Target Price
- TWST $49.10
- BCRX $16.70
- AVG Volume (30 Days)
- TWST 1.8M
- BCRX 3.5M
- Earning Date
- TWST 08-04-2025
- BCRX 08-04-2025
- Dividend Yield
- TWST N/A
- BCRX N/A
- EPS Growth
- TWST N/A
- BCRX N/A
- EPS
- TWST N/A
- BCRX N/A
- Revenue
- TWST $362,273,000.00
- BCRX $557,506,000.00
- Revenue This Year
- TWST $22.75
- BCRX $37.96
- Revenue Next Year
- TWST $17.63
- BCRX $8.82
- P/E Ratio
- TWST N/A
- BCRX N/A
- Revenue Growth
- TWST 22.72
- BCRX 45.85
- 52 Week Low
- TWST $24.28
- BCRX $6.02
- 52 Week High
- TWST $55.33
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- TWST 39.95
- BCRX 46.82
- Support Level
- TWST $24.28
- BCRX $8.08
- Resistance Level
- TWST $31.20
- BCRX $8.64
- Average True Range (ATR)
- TWST 1.97
- BCRX 0.33
- MACD
- TWST -0.34
- BCRX 0.06
- Stochastic Oscillator
- TWST 35.51
- BCRX 43.90
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.